Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 1, 2013, Pages 61-68

  Ricco, S ^a   Renzi, S ^b   Del Bue, M ^a   Conti, V ^a   Merli, E ^a   Ramoni, R ^a   Lucarelli, E ^c   Gnudi, G ^a   Ferrari, M ^b   Grolli, Stefano ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL EMILIA ROMAGNA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Adipose tissue derived mesenchymal stem cells; Allogeneic cell therapy; Horse tendonitis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; CELL THERAPY; CONTROLLED STUDY; HORSE; MESENCHYMAL STEM CELL; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; SUPERFICIAL DIGITAL FLEXOR TENDONITIS; TENDINITIS; THROMBOCYTE RICH PLASMA; ADIPOSE TISSUE; ALLOTRANSPLANTATION; ANIMAL; ANIMAL DISEASE; CYTOLOGY; HORSE DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; FEMALE; FLEXOR TENDON; FOLLOW UP; FRACTURE HEALING; MALE; OUTCOME ASSESSMENT; OVEREXERTION; TISSUE REACTION; ULTRASOUND;

ADIPOSE TISSUE; ANIMALS; HORSE DISEASES; HORSES; MESENCHYMAL STEM CELL TRANSPLANTATION; PLATELET-RICH PLASMA; TENDINOPATHY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84886745110     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/03946320130260S108     Document Type: Article

References (35)

1. Dyson SJ. Medical management of superfical digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine vet J 2004; 36:415-419.
2. Dowling BA, Dart AJ, Hodgson DR, Smith RK. Superficial digital flexor tendonitis in the horse. Equine vet J 2000; 32:369-378.
3. Dahlgren LA, Mohammed HO, Nixon AJ. Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 2005; 23:84-92.
4. Crevier-Denoix N, Collobert C, Pourcelot P, Denoix JM, Sanaa M, Geiger D, Bernard N, Ribot X, Bortolussi C, Bousseau B. Mechanical properties of pathological equine superficial digital flexor tendons. Equine vet J 1997; Suppl. 23-26.
5. Richardson LE, Dudhia J, Clegg PD, Smith R. Stem cells in veterinary medicine - attempts at regenerating equine tendon after injury. Trends Biotechnol 2007; 25:409-416.
6. Williams IF, Heaton A, McCullagh, K.G. Cell morphology and collagen types in equine tendon scar. Res Vet Sci 1980; 28:302-310.
7. Fortier LA, Smith RKW. Regenerative Medicine for Tendinous and Ligamentous Injuries of Sport Horses. Veternary Clinics of North America: Equine Practice 2008; 24:191-201.
8. Davis CS, Smith RKW. Diagnosis and management of tendon and ligament disorders. In: Equine Surgery, Eds: J.A. Auer and J.A. Stick, Elsevier Saunders, St Louis, 2006; pp 1086-1111.
9. Reef VB. Superficial digital flexor tendon healing: ultrasonographic evaluation of therapies. Vet Clin North Am Equine Pract. 2001; 17(1):159-78.
10. Goodship AE, Birch HL, Wilson AM. The pathobiology and repair of tendon and ligament injure. Vet. Clin. North Am. Equine Pract. 1994; 10:323-349.
11. Smith RKW. Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 2008; 30:1752-1758.
12. Longo UG, Lamberti A, Maffulli N, Denaro V. Tissue engineered biological augmentation for tendon healing: a systematic review. Br. Med. Bull. 2011; 98:31-59.
13. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 2009; 218:237-245.
14. Frisbie DD, Smith RKW. Clinical update on the use of mesenchymal stem cells in equine orthopaedics. Equine vet. J. 2010; 42:86-89.
15. Torricelli P, Fini M, Filardo G, Tschon M, Pischedda M, Pacorini A, Kon E, and Giardino R. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop 2011; 35:1569-1576.
16. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RKW. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine vet J 2012; 44:25-32.
17. Nixon AJ, Dahlgren LA, Haupt JL, Yeager AE, Ward DL. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008; 69:928-937.
18. Frisbie DD, Smith RKW Clinical update on the use of mesenchymal stem cells in equine orthopaedics. Equine vet J 2010; 42:86-89.
19. Reef VB. Musculoskeletal Ultrasonography. In: Equine Diagnostic Ultrasound Ed. WB Saunders Company, Philadelphia. 1998; pp.139-186
20. Donofrio G, Capocefalo A, Franceschi V, Morini G, Del Bue M, Conti V, Cavirani S, Grolli S. Virally and physically transgenized equine adipose-derived stromal cells as a cargo for paracrine secreted factors. BMC Cell Biol. 2010; 11:73.
21. Guest DJ, Smith MRW, Allen WR. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine vet J 2010; 42:636-642.
22. Schnabel LV, Lynch ME, Van Der Meulen MC, Yeager AE, Kornatowski MA, Nixon AJ. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res 2009; 27:1392-1398.
23. Crovace A, Lacitignola L, Rossi G, Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int 2010; 250978.
24. Del Bue M, Riccò S, Ramoni R, Conti V, Gnudi G, Grolli S. Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo. Vet Res Commun 2008; 32: Suppl 1 S51-55.
25. Pacini S, Spinabella S, Trombi L, Fazzi R, Galimberti S, Dini F, Carlucci F, Petrini M. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng 2007; 3:2949-2955.
26. Niemeyer P, Kornacker M, Mehlhorn A, Seckinger A, Vohrer J, Schmal H, Kasten P, Eckstein V, Südkamp NP, Krause U. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng 2007; 13:111-121.
27. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110:3499-3506.
28. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28:585-596.
29. Guest DJ, Smith MRW and Allen, W. R. (2008) Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: Preliminary study. Equine vet J 40, 178-181.
30. Carrade DD, Lame MW, Kent MS, Clark KC, Walker NJ, Borjesson DL. Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells. Cell Med 2012; 4(1):1-11.
31. Baxter M.A., Wynn R.F., Jowitt S.N., Wraith J.E., Fairbairn L.J. and Bellantuono I. (2004) Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22(5), 675-682.
32. Watts AE, Yeager AE, Kopyov OV, Nixon AJ Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model. Stem Cell Res Ther 2011;2(1):4.
33. Meirelles L da S, Fontes AM, Covas DT, Caplan AI Mechanisms involved in the therapeutic properties of mesenchymal stern cells. Cytokine Growth Factor Rev 2009; 20:419-427.
34. Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 2011; 12:126-131.
35. Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther 2010; 10(10):1415-26.